Full Professorship

"Research for a life without cancer" is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts - whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.

Ihre Aufgaben

The DKFZ, together with the Medical Faculty Heidelberg of Heidelberg University, is looking for an internationally outstanding scientist specialized in the field of immunology. The ideal candidate will conduct a pioneering research program focusing on the characterization of mechanisms that influence the development of immune cell responses against viral infections and cancer with a particular focus on T cells and NK cells. This joint appointment will be an integral part of the new research program "Immunology, Infection and Cancer", and will significantly strengthen it with additional expertise in infection and tumor immunology. The professorship will further develop the research field of immunology on an interdisciplinary and cross-institutional basis embracing innovative research fields such as tumor-asscoiated microbiome, immunometabolism and synthetic immunology. The professorship is expected to make a significant contribution to further expanding Heidelberg's leading international position in the field of immunology, as well as further strengthening and consolidating the strategic alliance between the DKFZ and Medical Faculty Heidelberg at Heidelberg University.

The candidate will work closely with other divisions and instituts in the field of immunology, infection biology and tumor immunology, developing novel concepts that can be applied to other human diseases. We are looking for a candidate with a strong focus on basic immunology who is interested in the differentiation and plasticity of immune cells in infectious diseases and cancer in model systems and in humans in the context of tumor and infectious diseases. The candidate should have a strong desire to work with institutions and clinical units on the Heidelberg campus that focus on translational research in infectious diseases and tumor immunology in order to co-develop innovative immune interventions for the treatment of these diseases. The ideal candidate will also have comprehensive knowledge in clinical immunology, microbiology or virology to bridge her/his research program to the University Hospitals in Heidelberg and Mannheim, the National Center for Tumor Diseases (NCT) and the translational networks (German Cancer Consortium (DKTK) and German Center for Infectious Diseases (DZIF)).

The W3-Professorship will be established as part of the new Immunology, Infection and Cancer research program at the German Cancer Research Center (DKFZ). This research program is complemented by a number of DKFZ research divisions and groups in the fields of genomics, data science and clinical translation. The successful candidate will have access to the research networks of the DKFZ and the National Cancer Prevention Center (NCPC) in Heidelberg, which is currently being established in a partnership between the DKFZ and the German Cancer Aid (Deutsche Krebshilfe), DKTK, NCT, the network of Comprehensive Cancer Centers (CCC) of the German Cancer Aid and other research alliances at national and international level.

Prerequisites for the application are a completed university degree, a qualifying doctorate (MD and/or PhD in life sciences) and other recruitment requirements specified in § 47 and § 48 (2) of the Baden-Württemberg State Higher Education Act (LHG). The joint appointment follows the "Jülicher Modell", where the successful candidate will be appointed as a full and lifetime professor at Heidelberg University and granted a leave of absence to the DKFZ to lead the division "Immunology". If the general civil service and budgetary requirements are met, the appointment to the professorship is usually made directly on the basis of a lifetime civil servant status (Beamtenverhältnis auf Lebenszeit).

We encourage candidates who have an outstanding track record of impactful, groundbreaking publications and independent, internationally competitively acquired third-party funding to apply. The successful candidate should demonstrate leadership qualities in terms of guiding and mentoring junior scientists and have the ability to foster a scientifically stimulating and inclusive research environment.

Wir bieten Ihnen

A highly supportive research environment at the DKFZ, the National Cancer Prevention Center (NCPC) and the wider scientific community including Heidelberg University as well as opportunities for national and international networking at the highest level

Kontakt

Applications must be submitted by January 17, 2025, including curriculum vitae, copies of certificates and degrees, list of publications, a research concept, and a list of teaching experience through the DKFZ online application tool (www.dkfz.de/jobs) to Prof. Dr. Dr. h. c. Michael Baumann, Scientific Director and Chair of the Management Board, German Cancer Research Center (DKFZ), as well as to Prof. Dr. Michael Boutros, Dean of the Medical Faculty Heidelberg of Heidelberg University via the application management of the Medical Faculty Heidelberg (https://berufungsportal.medizinische-fakultaet-hd.uni-heidelberg.de). We ask for your understanding that application documents submitted by mail will not be returned., Prof. Dr. med. Dr. h.c. Michael Baumann Telefon: +49 (0)6221/42-2850 Duration: The position is permanent. Application Deadline: 17.01.2025 Applications by e-mail cannot be accepted.